Pathological Hallmarks, Clinical Parallels, and Value for Drug Testing in Alzheimer's Disease of the APP[V717I] London Transgenic Mouse Model
Authors:
Open Access
- 1 January 2010
- journal article
- Published by Hindawi Limited in International Journal of Alzheimer's Disease
- Vol. 2010, 1-9
Abstract
The APP[V717I] London (APP-Ld) mouse model recapitulates important pathological and clinical hallmarks of Alzheimer's disease (AD) and is therefore a valuable paradigm for evaluating therapeutic candidates. Historically, both the parenchymal and vascular amyloid deposits, and more recently, truncated and pyroglutamate-modified Abet species, are perceived as important hallmarks of AD-pathology. Late stage symptoms are preceded by robust deficits in orientation and memory that correlate in time with Abeta oligomerization and GSK3-mediated phosphorylation of endogenous murine Tau, all markers that have gained considerable interest during the last decade. Clinical parallels with AD patients and the value of the APP-Ld transgenic mouse model for preclinicalin vivotesting of candidate drugs are discussed.Keywords
This publication has 44 references indexed in Scilit:
- Alzheimer's disease: Old problem, new views from transgenic and viral modelsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- Of Mice and MenCNS Drugs, 2009
- Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunctionNeurobiology of Disease, 2009
- Intraneuronal pyroglutamate-Abeta 3–42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse modelActa Neuropathologica, 2009
- Epilepsy and Cognitive Impairments in Alzheimer DiseaseArchives of Neurology, 2009
- Neprilysin Overexpression Inhibits Plaque Formation But Fails to Reduce Pathogenic Aβ Oligomers and Associated Cognitive Deficits in Human Amyloid Precursor Protein Transgenic MiceJournal of Neuroscience, 2009
- Amyloid Activates GSK-3β to Aggravate Neuronal Tauopathy in Bigenic MiceThe American Journal of Pathology, 2008
- An in vitro and in vivo study of early deficits in associative learning in transgenic mice that over‐express a mutant form of human APP associated with Alzheimer's diseaseEuropean Journal of Neuroscience, 2004
- Additive Effects of PS1 and APP Mutations on Secretion of the 42-Residue Amyloid β-ProteinNeurobiology of Disease, 1998
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991